Thomas Molinaro, MD, MSCE

Jessica Medvedich is Executive Director of Clinical Operations for Everleap Fertility, bringing more than a decade of leadership experience in reproductive medicine. A Board-Certified Nurse Executive, she entered fertility care in 2006 through specialty pharmacy, developing expertise in fertility medications and patient education before joining Everleap Fertility New Jersey (formerly RMA New Jersey) as a fertility nurse in 2011. She advanced through clinical and management roles and now leads clinical operations across Everleap’s North American network, helping standardize care and strengthen patient safety and quality. A frequent national speaker on reproductive medicine operations, Jessica serves as a Director-at-Large for the American Society for Reproductive Medicine and on the Board of ASRM’s Association of Reproductive Managers. She earned her BSN from The College of New Jersey and MBA from the University of Texas at Tyler.

Dr. Scott J. Morin, MD, FACOG, is Physician Partner and West Coast Medical Director for Everleap Fertility and a double board-certified reproductive endocrinologist. As a trained embryologist and reproductive endocrinologist, he brings rare expertise in both the clinical and laboratory science behind IVF. His research has advanced understanding of embryo development, single embryo transfer and preimplantation genetic testing and earned multiple national honors, including the Society for Reproductive Investigation/Pfizer President’s Presenter Award, Society for Male Reproduction and Urology Traveling Scholar Award and Society for Reproductive Biology and Technology Clinical Science Award. He has published extensively and presented his research internationally. Dr. Morin earned his MD from UC Irvine and completed his residency at NYU. 

Dr. Maria Costantini-Ferrando is Physician Partner and East Coast Medical Director for Everleap Fertility and a board-certified reproductive endocrinologist and obstetrician-gynecologist. With advanced training in both clinical psychology and reproductive medicine, she brings a rare understanding of the emotional and psychological aspects of infertility to Everleap’s clinical and patient-facing teams across the country, elevating emotional care alongside medical excellence. Her research has helped advance fertility preservation for women facing cancer treatment. She also has expertise in male infertility, IVF and the hormonal and stress-related factors influencing ovarian response. As a principal investigator of groundbreaking research examining the impact of stress on IVF outcomes, she has deepened industry understanding of the connection between psychological and reproductive health. Dr Costantini-Ferrando was named a 2026 NJ Top Doctor and NJBIZ People to Watch in Healthcare. She earned her PhD from Northwestern and MD from Weill Cornell. 

Dr. Alan Penzias, a world-leading reproductive endocrinologist and Northeast Regional Medical Director for Everleap Fertility, brings 30 years of clinical, research and academic leadership to the field. He is an Associate Professor at Harvard Medical School and directs fellowship training in reproductive endocrinology and infertility at Beth Israel Deaconess Medical Center. His leadership has helped shape clinical standards and policy through service on the ASRM Board, SART Executive Council and World Health Organization Infertility Global Guidelines and Research Group, among others. Dr. Penzias has authored more than 250 scientific and clinical publications, including more than 100 original peer-reviewed papers, and has been named a Castle Connolly and Boston Magazine Top Doctor for 18 consecutive years. He earned his M.D. from SUNY Downstate and completed his residency at Beth Israel and fellowship at Yale and is double board-certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. 

Dr. Sony Sierra, MD, FRCSC, is a Reproductive Endocrinologist and Infertility Specialist, Medical Director and Partner at TRIO Fertility and Evolve Egg Freeze, an Everleap Fertility company under the Global IVI Institute. She has specialized in infertility and recurrent pregnancy loss for over two decades and co-leads TRIO’s Recurrent Pregnancy Loss program, the largest in Canada.   A former President of the Canadian Fertility and Andrology Society and lead author of the 2025 Canadian clinical practice guideline, she has shaped clinical guidance for recurrent pregnancy loss nationwide. She is also an Associate Physician at Women’s College Hospital and Assistant Professor of Obstetrics and Gynecology at the University of Toronto. Her clinical and research interests include recurrent early pregnancy loss, implantation failure and fertility preservation. She earned her MD from the University of Toronto and is certified by the Royal College of Physicians and Surgeons of Canada in Obstetrics and Gynecology and Gynecologic Reproductive Endocrinology and Infertility.